Search
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2022
- December 20222 results available
- November 20221 results available
- October 20223 results available
- September 20223 results available
- August 20221 results available
- July 20221 results available
- June 20221 results available
- May 20221 results available
- April 20222 results available
- March 20223 results available
- February 20222 results available
- January 20224 results available
Displaying 16 - 24 of 24 items.
Sodium Acetate Injection, USP - Potential for the Presence of Particulate Matter
AlertHealth professional risk communication | 2022-03-15
Anticipated shortage of euthanasia products for animals
AlertHealth professional risk communication | 2022-03-10
0.9% Sodium Chloride Injection, USP and Lactated Ringer’s Injection, USP - Potential Leak During Pressure Infusion
AlertHealth professional risk communication | 2022-03-09
Distribution of NUVAXOVID with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2022-02-23
BEOVU (brolucizumab) – Risk of Intraocular Inflammation, Retinal Vasculitis and/or Retinal Vascular Occlusion
AlertHealth professional risk communication | 2022-02-03
PAXLOVID (nirmatrelvir and ritonavir) - Dosing and Dispensing in Renal Impairment, Risk of Serious Adverse Reactions Due to Drug Interactions, and English-Only Labels
AlertHealth professional risk communication | 2022-01-17
XELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection
AlertHealth professional risk communication | 2022-01-12
Shelf Life Extension for the SPIKEVAX (elasomeran) COVID-19 Vaccine with Printed Expiry Dates on Vial and Carton Labels
AlertHealth professional risk communication | 2022-01-11
Casirivimab and Imdevimab – High Risk of Treatment Failure Due to Circulation of SARS-CoV-2 Omicron Variant
AlertHealth professional risk communication | 2022-01-07